logo

Emergent Biosolutions Inc (EBS) Stock: 52-Week Performance Insights and Trading Volume

TOST Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Emergent Biosolutions Inc’s current trading price is -62.64% away from its 52-week high, while its distance from the 52-week low is 186.21%. The stock’s price range for this period has been between $1.42 and $10.88 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 103.15 million for the day, a number notably higher than the average daily volume of 3.06 million over the last three months.

In terms of market performance, Emergent Biosolutions Inc had a fairly uneven. The highest value for the stock in the past year was $10.88 on 05/11/23, and the lowest value was recorded at $1.42 on 02/06/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Emergent Biosolutions Inc (EBS) has experienced a quarterly rise of 146.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 212.15M and boasts a workforce of 1600 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2531, with a change in price of +1.6950. Similarly, Emergent Biosolutions Inc recorded 3,365,764 in trading volume during the last 100 days, posting a change of +70.04%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for EBS stands at 1.36. Similarly, the long-term debt-to-equity ratio is also 0.67.

EBS Stock Stochastic Average

As of today, Emergent Biosolutions Inc’s raw stochastic average for the last 50 days stands at 80.38%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 80.38%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 36.39% and 20.50%, respectively.

EBS Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 69.34% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 94.46%. Over the past 30 days, the price of EBS has fallen by 79.83%. And in the last five days, it has surged by 108.42%.

Most Popular